RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mochida Pharmaceutical Co - Stock

Mochida Pharmaceutical Co Revenue 2024

Mochida Pharmaceutical Co Revenue

102.89 B JPY

Ticker

4534.T

ISIN

JP3922800002

WKN

859288

In 2024, Mochida Pharmaceutical Co's sales reached 102.89 B JPY, a -0.36% difference from the 103.26 B JPY sales recorded in the previous year.

The Mochida Pharmaceutical Co Revenue history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)
2027e111.146,87
2026e109.0847,74
2025e107.0648,64
2024102.8950,61
2023103.2653,37
2022110.1854,05
202110353,20
2020101.851,00
2019109.6449,40
2018106.7650,19
201797.3557,84
201692.2759,61
201587.2561,13
201493.9563,42
201389.2163,24
201286.2165,38
201179.3461,72
201078.5562,95
200975.1861,90
200874.5761,88
200774.0760,22
200670.6361,70
200568.0459,86

Mochida Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Mochida Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Mochida Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Mochida Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Mochida Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Mochida Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Mochida Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Mochida Pharmaceutical Co’s growth potential.

Mochida Pharmaceutical Co Revenue, EBIT and net profit per share

DateMochida Pharmaceutical Co RevenueMochida Pharmaceutical Co EBITMochida Pharmaceutical Co Net Income
2027e111.1 B undefined0 undefined7.46 B undefined
2026e109.08 B undefined0 undefined6.7 B undefined
2025e107.06 B undefined0 undefined5.95 B undefined
2024102.89 B undefined5.8 B undefined4.55 B undefined
2023103.26 B undefined8.51 B undefined6.65 B undefined
2022110.18 B undefined14.39 B undefined10.57 B undefined
2021103 B undefined12 B undefined8.59 B undefined
2020101.8 B undefined8.81 B undefined4.6 B undefined
2019109.64 B undefined10.59 B undefined8.44 B undefined
2018106.76 B undefined11.66 B undefined9.02 B undefined
201797.35 B undefined11.37 B undefined8.53 B undefined
201692.27 B undefined12.15 B undefined8.15 B undefined
201587.25 B undefined10.98 B undefined7.54 B undefined
201493.95 B undefined16.6 B undefined9.89 B undefined
201389.21 B undefined14.02 B undefined9.15 B undefined
201286.21 B undefined14.93 B undefined9.08 B undefined
201179.34 B undefined11.51 B undefined5.33 B undefined
201078.55 B undefined13.95 B undefined9.87 B undefined
200975.18 B undefined12.83 B undefined8.75 B undefined
200874.57 B undefined11.74 B undefined8.39 B undefined
200774.07 B undefined10.02 B undefined6.03 B undefined
200670.63 B undefined8.55 B undefined4.96 B undefined
200568.04 B undefined4.77 B undefined2.27 B undefined

Mochida Pharmaceutical Co stock margins

The Mochida Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Mochida Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Mochida Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Mochida Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Mochida Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Mochida Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Mochida Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Mochida Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Mochida Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Mochida Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Mochida Pharmaceutical Co Margin History

Mochida Pharmaceutical Co Gross marginMochida Pharmaceutical Co Profit marginMochida Pharmaceutical Co EBIT marginMochida Pharmaceutical Co Profit margin
2027e50.61 %0 %6.71 %
2026e50.61 %0 %6.14 %
2025e50.61 %0 %5.56 %
202450.61 %5.64 %4.42 %
202353.37 %8.24 %6.44 %
202254.05 %13.06 %9.59 %
202153.2 %11.65 %8.34 %
202051 %8.65 %4.52 %
201949.4 %9.66 %7.69 %
201850.19 %10.92 %8.45 %
201757.84 %11.68 %8.76 %
201659.61 %13.17 %8.83 %
201561.13 %12.58 %8.65 %
201463.42 %17.67 %10.53 %
201363.24 %15.71 %10.26 %
201265.38 %17.32 %10.53 %
201161.72 %14.51 %6.72 %
201062.95 %17.76 %12.56 %
200961.9 %17.06 %11.64 %
200861.88 %15.74 %11.25 %
200760.22 %13.53 %8.14 %
200661.7 %12.11 %7.02 %
200559.86 %7.01 %3.34 %

Mochida Pharmaceutical Co Aktienanalyse

What does Mochida Pharmaceutical Co do?

Mochida Pharmaceutical Co Ltd is a Japanese pharmaceutical company based in Tokyo. The company has been in the industry for over 100 years and has become one of the leading providers of medications and health products in Japan and worldwide. The history of Mochida Pharmaceutical begins in 1913 when Shoyo Mochida founded the company. Initially, the company specialized in the production of vitamins and later expanded its product range to include other pharmaceutical products. Over the following decades, the company steadily grew and expanded internationally. Today, Mochida Pharmaceutical is involved in various areas of healthcare. The company offers a wide range of medications for the treatment of various diseases and ailments, including cardiovascular diseases, diabetes, cancer, infectious diseases, and mental illnesses. Mochida Pharmaceutical is also involved in other areas of healthcare. The company manufactures and distributes various medical devices and diagnostics, including a wide range of medical instruments such as endoscopes and ultrasound devices, as well as tests and reagents for the diagnosis of infectious diseases and other conditions. A major focus of Mochida Pharmaceutical's business model is research and development of new products. The company has an extensive research and development department that continuously works on the development of new medications and technologies. Mochida Pharmaceutical collaborates closely with various universities and research institutes to develop new insights and technologies. In addition to the production and distribution of medications and medical devices, Mochida Pharmaceutical is also engaged in health promotion and prevention. The company offers various health services and products aimed at helping people live healthier lives and take better care of their health. Over the years, the company has achieved several important milestones. In 1970, Mochida Pharmaceutical successfully developed an immunosuppressive medication that is now known as Tacrolimus and is used to prevent organ transplant rejection. Other significant milestones include the introduction of medications for the treatment of diabetes and cancer, as well as the development of new technologies such as transdermal patches for medication administration. Mochida Pharmaceutical is now a globally operating company with branches in various countries. The company employs thousands of employees worldwide and has a strong presence in all major markets. The company is committed to further expanding its position as a leading provider of medical products and services and focusing on the needs of its customers and patients. Mochida Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Mochida Pharmaceutical Co's Sales Figures

The sales figures of Mochida Pharmaceutical Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Mochida Pharmaceutical Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Mochida Pharmaceutical Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Mochida Pharmaceutical Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Mochida Pharmaceutical Co Stock

How much revenue did Mochida Pharmaceutical Co generate this year?

Mochida Pharmaceutical Co has achieved a revenue of 102.89 B JPY this year.

How much was the turnover of the company Mochida Pharmaceutical Co compared to the previous year?

The revenue of Mochida Pharmaceutical Co has increased by -0.36% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Mochida Pharmaceutical Co?

The revenue of Mochida Pharmaceutical Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Mochida Pharmaceutical Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Mochida Pharmaceutical Co so important for investors?

The revenue of Mochida Pharmaceutical Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Mochida Pharmaceutical Co pay?

Over the past 12 months, Mochida Pharmaceutical Co paid a dividend of 80 JPY . This corresponds to a dividend yield of about 2.57 %. For the coming 12 months, Mochida Pharmaceutical Co is expected to pay a dividend of 83.96 JPY.

What is the dividend yield of Mochida Pharmaceutical Co?

The current dividend yield of Mochida Pharmaceutical Co is 2.57 %.

When does Mochida Pharmaceutical Co pay dividends?

Mochida Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Mochida Pharmaceutical Co?

Mochida Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Mochida Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 83.96 JPY are expected. This corresponds to a dividend yield of 2.7 %.

In which sector is Mochida Pharmaceutical Co located?

Mochida Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mochida Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mochida Pharmaceutical Co from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Mochida Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Mochida Pharmaceutical Co in the year 2023?

In the year 2023, Mochida Pharmaceutical Co distributed 80 JPY as dividends.

In which currency does Mochida Pharmaceutical Co pay out the dividend?

The dividends of Mochida Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mochida Pharmaceutical Co

Our stock analysis for Mochida Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mochida Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.